Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing
about
Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.Ventilator-associated pneumonia: diagnosis, treatment, and preventionClinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa.Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients.Prospective monitoring of cefepime in intensive care unit adult patientsHigh cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic.Continuous infusion of piperacillin/tazobactam in septic critically ill patients--a multicenter propensity matched analysis.Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function.Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery.Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapyAntibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignanciesPopulation Pharmacokinetics of Fosfomycin in Critically Ill Patients.Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Continuous beta-lactam infusion in critically ill patients: the clinical evidenceCefepime: a reappraisal in an era of increasing antimicrobial resistance.Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumonia.Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.
P2860
Q24813204-DABE15CC-85F2-4F6B-8144-3A380C766E07Q29012676-6234199E-02B6-4218-8297-FF7278C24980Q33676227-C904A2B3-3A4B-4FB7-8C16-F9199A413316Q33751132-FA986BAC-02F9-4CE6-92D2-91BF9D705203Q33824276-0D35943D-CF6B-4A39-A203-51D22B3D806DQ33919165-FD4791B3-DD63-4F17-9279-0ADF2675C693Q34150967-A84300AC-D913-4F89-9C16-E45ADF61D39DQ34153182-EBE61D4E-F1BF-4D7F-9784-5C0E9D9FF8F5Q34329290-335061CF-BCC1-4FC3-BD5D-C06544279BE9Q34490565-C71D6C85-D230-476D-B0A1-DFFC8F198521Q35013708-6FA9D085-95EA-4E61-B522-92643114A431Q35364423-FD3A86CB-CAE2-4D3F-84F3-8E0A9915E92EQ35558292-A2C31A77-6EB9-4B57-BDD1-1FAA55466DCEQ35908084-92DD011A-474C-4C05-A1DE-C96D71D95278Q35960873-0798F065-79BF-47F5-A282-EEEE01A7973DQ36075930-2B06C764-3997-4D98-A0BE-B472A825008EQ36287127-B4C108F1-2EB8-495F-8B1B-C5473A237231Q36329228-FD945D8B-6C66-4AF7-B5A0-D82C81AE2B44Q37079350-9680F45F-FB36-4789-B100-08E5DB2AE249Q37643682-E6444B10-11EA-49C3-AF55-3D8E0F36620BQ43153489-63F44167-BCA6-4A87-8DC8-7B40F2290BBA
P2860
Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Low plasma cefepime levels in ...... ed troughs with revised dosing
@ast
Low plasma cefepime levels in ...... ed troughs with revised dosing
@en
type
label
Low plasma cefepime levels in ...... ed troughs with revised dosing
@ast
Low plasma cefepime levels in ...... ed troughs with revised dosing
@en
prefLabel
Low plasma cefepime levels in ...... ed troughs with revised dosing
@ast
Low plasma cefepime levels in ...... ed troughs with revised dosing
@en
P2093
P2860
P1476
Low plasma cefepime levels in ...... ed troughs with revised dosing
@en
P2093
P2860
P304
P407
P577
1999-10-01T00:00:00Z